Cargando…

Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients

BACKGROUND: Specific clinical risk factors may contribute to improving or worsening neurological functions in acute ischemic stroke (AIS) patients pre-treated with a combined cholesterol reducer and recombinant tissue plasminogen activator (rtPA) therapy. In this study, clinical risk factors associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poupore, Nicolas, Strat, Dan, Mackey, Tristan, Brown, Katherine, Snell, Ashley, Nathaniel, Thomas I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201805/ https://www.ncbi.nlm.nih.gov/pubmed/32375780 http://dx.doi.org/10.1186/s12944-020-01270-2

Ejemplares similares

Ischemic stroke with a preceding Trans ischemic attack (TIA) less than 24 hours and thrombolytic therapy
por: Poupore, Nicolas, et al.
Publicado: (2020)

The Association Between an Antecedent of Transient Ischemic Attack Prior to Onset of Stroke and Functional Ambulatory Outcome
por: Poupore, Nicolas, et al.
Publicado: (2020)

Comorbidities associated with different levels of total cholesterol in male and female acute ischemic stroke patients
por: Brechtel, Leanne, et al.
Publicado: (2020)

Thrombolytic or endovascular therapy for acute ischemic stroke: Time is brain
por: Mijajlovic, Milija D.
Publicado: (2014)

Repeated Thrombolytic Therapy in Patients with Recurrent Acute Ischemic Stroke
por: Yoo, Han Soo, et al.
Publicado: (2013)

Susceptibility-weighted Imaging in Thrombolytic Therapy of Acute Ischemic Stroke
por: Li, Lin, et al.
Publicado: (2017)

Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy
por: Sanders, Carolyn Breauna, et al.
Publicado: (2022)

Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke
por: Alhadid, Kenda, et al.
Publicado: (2023)

Effects of Nursing Quality Improvement on Thrombolytic Therapy for Acute Ischemic Stroke
por: Liu, Zhuo, et al.
Publicado: (2018)

Paradoxical Myocardial Infarction After Thrombolytic Therapy for Acute Ischemic Stroke
por: Mohmand, Billal, et al.
Publicado: (2021)

Evolution of the Thrombolytic Treatment Window for Acute Ischemic Stroke
por: Stemer, Andrew, et al.
Publicado: (2010)

Are in-Hospital Delays Important Obstacles in Thrombolytic Therapy Following Acute Ischemic Stroke?
por: Choi, Jay Chol, et al.
Publicado: (2007)

CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective
por: Sillanpaa, Niko, et al.
Publicado: (2011)

Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
por: Mehrpour, Masoud, et al.
Publicado: (2013)

Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Thrombolytic Therapy
por: Kikule, Ilga, et al.
Publicado: (2022)

Safety and Efficacy of Thrombolytic Therapy Using rt-PA (Alteplase) in Acute Ischemic Stroke
por: Sivanandy, Palanisamy, et al.
Publicado: (2011)

Retrosternal mass: An interesting allergic reaction to intravenous thrombolytic therapy for acute ischemic stroke
por: Mehrpour, Masoud, et al.
Publicado: (2013)

Pentraxin-3 in Thrombolytic Therapy for Acute Ischemic Stroke: No Relation with Curative Effect and Prognosis
por: Zhang, Chun-Yang, et al.
Publicado: (2018)

Predictive Factors for Functional Outcomes After Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
por: Çetiner, Mustafa, et al.
Publicado: (2018)

Acute Ischemic Stroke in a Child Successfully Treated with Thrombolytic Therapy and Mechanical Thrombectomy
por: Souto Silva, Renata, et al.
Publicado: (2019)

Intravenous thrombolytic therapy in acute ischemic stroke: The art and science of treatment decision making
por: Sylaja, P. N., et al.
Publicado: (2008)

Retrospective Evaluation of the Results of Low-Dose Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
por: Cetiner, Mustafa, et al.
Publicado: (2023)

Acute Thrombolytic Therapy Combined with the Green Channel Can Reduce the Thrombolytic Time and Improve Neurological Function in Acute Stroke Patients
por: Hong, Zhen, et al.
Publicado: (2022)

Thrombolytic Therapy for Acute Stroke: The Hidden Dimension
por: Mansour, Ossama, et al.
Publicado: (2010)

Pharmaceutical Sponsorship Bias Influences Thrombolytic Literature in Acute Ischemic Stroke
por: Radecki, Ryan Patrick
Publicado: (2011)

In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke
por: Yang, Yilin, et al.
Publicado: (2023)

Retracted: Acute Thrombolytic Therapy Combined with the Green Channel Can Reduce the Thrombolytic Time and Improve Neurological Function in Acute Stroke Patients
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Disruptions of Circadian Rhythms and Thrombolytic Therapy During Ischemic Stroke Intervention
por: Liu, Jennifer A., et al.
Publicado: (2021)

Metabolomic Profiles of Men and Women Ischemic Stroke Patients
por: Poupore, Nicolas, et al.
Publicado: (2021)

The Usefulness of the Kurashiki Prehospital Stroke Scale in Identifying Thrombolytic Candidates in Acute Ischemic Stroke
por: Jang, Jieun, et al.
Publicado: (2014)

Systemic Thrombolytic Therapy Alone and in Combination with Mechanical Revascularization in Acute Ischemic Stroke in Two Children
por: Modrau, B., et al.
Publicado: (2011)

Eligibility Assessment for Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients; Evaluating Barriers for Implementation
por: Ayromlou, Hormoz, et al.
Publicado: (2014)

Knowledge of Thrombolytic Therapy for Acute Ischemic Stroke among Community Residents in Western Urban China
por: Yang, Juan, et al.
Publicado: (2014)

Outcomes of thrombolytic therapy in acute ischemic stroke: mothership, drip-and-ship, and ship-and-drip paradigms
por: Kijpaisalratana, Naruchorn, et al.
Publicado: (2020)

Renal Dysfunction and In‐Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy
por: Rao, Zhen‐Zhen, et al.
Publicado: (2019)

Stroke Severity among Men and Women Acute Ischemic Stroke Patients in the Telestroke Network
por: Poupore, Nicolas, et al.
Publicado: (2022)

Computational Simulations of Thrombolytic Therapy in Acute Ischaemic Stroke
por: Piebalgs, Andris, et al.
Publicado: (2018)

Improper Use of Thrombolytic Agents in Acute Hemiparesis Following Misdiagnosis of Acute Ischemic Stroke
por: Kim, Min Chan, et al.
Publicado: (2018)

Increased Oxidative Stress Markers in Acute Ischemic Stroke Patients Treated with Thrombolytics
por: Pawluk, Hanna, et al.
Publicado: (2022)

Renal Dysfunction and Thrombolytic Therapy in Patients With Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Hao, Zilong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cinabng402resm2jgc64gclbdr